EE471 Cost Effectiveness of Newborn Screening (NBS) for Spinal Muscular Atrophy (SMA) in England
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.716
https://www.valueinhealthjournal.com/article/S1098-3015(22)02920-5/fulltext
Title :
EE471 Cost Effectiveness of Newborn Screening (NBS) for Spinal Muscular Atrophy (SMA) in England
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02920-5&doi=10.1016/j.jval.2022.09.716
First page :
Section Title :
Open access? :
No
Section Order :
10255